{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:30:10Z","timestamp":1793115010098,"version":"4.5.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014349","name":"Society For Maternal-Fetal Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ajog.2023.10.031","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:05:19Z","timestamp":1697846719000},"page":"B17-B40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy"],"prefix":"10.1016","volume":"230","author":[{"given":"Rachel G.","family":"Sinkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foluso J.","family":"Ogunsile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Kanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4Suppl","key":"10.1016\/j.ajog.2023.10.031_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S. American","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.AOG.0000127433.23611.54","article-title":"Outcome of pregnancy in homozygous sickle cell disease","volume":"103","author":"Serjeant","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/17474086.2022.2151432","article-title":"Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care","volume":"15","author":"Moukalled","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-030-41769-7_12","article-title":"Sickle cell hemoglobin","volume":"94","author":"Mandal","year":"2020","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.ajog.2023.10.031_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-198602000-00012","article-title":"Pregnancy in sickle cell disease","volume":"67","author":"Powars","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib9","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.10.031_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/CEOR.S276121","article-title":"Development of a severity classification system for sickle cell disease","volume":"12","author":"Shah","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.ajog.2023.10.031_bib11","first-page":"1300","article-title":"Screening for sickle cell disease in newborns: recommendation statement","volume":"77","author":"United States Preventive Services Task Force","year":"2008","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.ajog.2023.10.031_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/03630260701297071","article-title":"Diagnostic approach to hemoglobinopathies","volume":"31","author":"Kutlar","year":"2007","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ajog.2023.10.031_bib13","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","article-title":"ACOG Committee Opinion No. 691: carrier screening for genetic conditions","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4Suppl","key":"10.1016\/j.ajog.2023.10.031_bib14","doi-asserted-by":"crossref","first-page":"S536","DOI":"10.1016\/j.amepre.2010.01.001","article-title":"Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007","volume":"38","author":"Yusuf","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib15","series-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]","article-title":"Characteristics of inpatient hospital stays involving sickle cell disease, 2000-2016","author":"Fingar","year":"2006"},{"key":"10.1016\/j.ajog.2023.10.031_bib16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2141.1994.tb08317.x","article-title":"The painful crisis of homozygous sickle cell disease: clinical features","volume":"87","author":"Serjeant","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajog.2023.10.031_bib18","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib19","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2023.10.031_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib23","doi-asserted-by":"crossref","first-page":"505.e1","DOI":"10.1016\/j.ajog.2016.05.032","article-title":"Contemporary outcomes of sickle cell disease in pregnancy","volume":"215","author":"Kuo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib24","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","article-title":"Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis","volume":"125","author":"Oteng-Ntim","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2023.10.031_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/1471-0528.13786","article-title":"Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis","volume":"123","author":"Boafor","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.10.031_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/thoraxjnl-2019-213796","article-title":"Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis","volume":"75","author":"Inparaj","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.ajog.2023.10.031_bib27","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ajh.26063","article-title":"Impact of sickle cell disease on patients\u2019 daily lives, symptoms reported, and disease management strategies: results from the international sickle cell world Assessment Survey (SWAY)","volume":"96","author":"Osunkwo","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib29","first-page":"e320","article-title":"American College of Obstetricians and Gynecologists' Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins\u2014Obstetrics. ACOG Practice Bulletin No. 212: pregnancy and heart disease","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words \u2013 racism and sickle cell disease","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.hoc.2022.08.008","article-title":"Structural racism and impact on sickle cell disease: sickle cell lives matter","volume":"36","author":"Smith","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ajog.2023.10.031_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/bjh.17671","article-title":"Management of sickle cell disease in pregnancy. A British Society for Haematology guideline","volume":"194","author":"Oteng-Ntim","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.fertnstert.2021.12.030","article-title":"Electronic address: asrm@asrm.org. Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion","volume":"117","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.031_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejogrb.2022.05.031","article-title":"Obstetric and perinatal risks after the use of donor sperm: a systematic review and meta-analysis","volume":"274","author":"Pohjonen","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.10.031_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0038-1667029","article-title":"The impact of sperm and egg donation on the risk of pregnancy complications","volume":"36","author":"Fishel Bartal","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.10.031_bib36","first-page":"CD011175","article-title":"Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications","volume":"10","author":"Asnani","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.10.031_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.10.031_bib38","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib39","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib40","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","article-title":"American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation","volume":"5","author":"Kanter","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10245332.2000.11746536","article-title":"The role of inflammation and leukocytes in the pathogenesis of sickle cell disease","volume":"5","author":"Wun","year":"2000","journal-title":"Hematology"},{"key":"10.1016\/j.ajog.2023.10.031_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2006.08.009","article-title":"White blood cell count as a predictor of the severity of sickle cell disease during pregnancy","volume":"133","author":"Litos","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.10.031_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5556708","article-title":"Orofacial manifestation and dental management of sickle cell disease: a scoping review","volume":"2021","author":"Kakkar","year":"2021","journal-title":"Anemia"},{"key":"10.1016\/j.ajog.2023.10.031_bib45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.adaj.2020.05.023","article-title":"Evidence-based dental management in the new era of sickle cell disease: a scoping review","volume":"151","author":"Hsu","year":"2020","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.ajog.2023.10.031_bib46","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/AOG.0000000000002703","article-title":"ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib47","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG Practice Bulletin No. 196: thromboembolism in pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2010.02.016","article-title":"Gastrointestinal and hepatic complications of sickle cell disease","volume":"8","author":"Ebert","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajog.2023.10.031_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1300\/J115v27n01_05","article-title":"REPROTOX: an information system on environmental hazards to human reproduction and development","volume":"27","author":"Fitzpatrick","year":"2008","journal-title":"Med Ref Serv Q"},{"key":"10.1016\/j.ajog.2023.10.031_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajmg.c.30310","article-title":"Teratogenic exposures","volume":"157C","author":"Obi\u010dan","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ajog.2023.10.031_bib51","first-page":"371","article-title":"Neonatal anuria with maternal angiotensin-converting enzyme inhibition","volume":"74","author":"Rosa","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/tera.1420440503","article-title":"ACE inhibitor fetopathy and hypocalvaria: the\u00a0kidney-skull connection","volume":"44","author":"Barr","year":"1991","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2023.10.031_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(00)03648-5","article-title":"Losartan and fetal toxic effects","volume":"357","author":"Saji","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.10.031_bib54","first-page":"1448","article-title":"The effects of hydroxyurea and related compounds on the rat fetus","volume":"26","author":"Chaube","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2023.10.031_bib55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0012-1606(71)90129-1","article-title":"DNA synthesis inhibition and cell death associated with hydroxyurea teratogenesis in rat embryos","volume":"26","author":"Scott","year":"1971","journal-title":"Dev Biol"},{"key":"10.1016\/j.ajog.2023.10.031_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/tera.1420110205","article-title":"Comparative distribution and embryotoxicity of hydroxyurea in pregnant rats and rhesus monkeys","volume":"11","author":"Wilson","year":"1975","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2023.10.031_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/096032719101000404","article-title":"The consequences of iron overdose and its treatment with desferrioxamine in pregnancy","volume":"10","author":"McElhatton","year":"1991","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.ajog.2023.10.031_bib58","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0002-9378(83)90457-X","article-title":"Iron overdose during pregnancy: successful therapy with deferoxamine","volume":"147","author":"Rayburn","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0609.2010.01569.x","article-title":"Normal pregnancy in a patient with \u03b2-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade\u00ae)","volume":"86","author":"Vini","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A\u00a0Phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.ajog.2023.10.031_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/bdrb.10008","article-title":"Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure","volume":"68","author":"Cappon","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2023.10.031_bib64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","article-title":"Nonsteroidal anti-inflammatory drugs in early pregnancy","volume":"15","author":"Ericson","year":"2001","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2023.10.031_bib65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","article-title":"Maternal medications and environmental exposures as risk factors for gastroschisis","volume":"54","author":"Torfs","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2023.10.031_bib66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0095-5108(18)30903-5","article-title":"Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn","volume":"11","author":"Turner","year":"1984","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2023.10.031_bib67","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/adc.54.12.942","article-title":"Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen","volume":"54","author":"Wilkinson","year":"1979","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ajog.2023.10.031_bib69","first-page":"47","article-title":"Teratogenic effects of the anticonvulsant gabapentin in mice","volume":"49","author":"Prakash","year":"2008","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ajog.2023.10.031_bib70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1006\/faat.1994.1144","article-title":"Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin","volume":"23","author":"Petrere","year":"1994","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.ajog.2023.10.031_bib71","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.0b013e31828f18c1","article-title":"Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study","volume":"80","author":"Fujii","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2023.10.031_bib72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1525-5050(03)00110-0","article-title":"Gabapentin exposure in human pregnancy: results from the gabapentin Pregnancy Registry","volume":"4","author":"Montouris","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ajog.2023.10.031_bib73","first-page":"1065","article-title":"Teratogenic effects of pregabalin in mice","volume":"16","author":"Etemad","year":"2013","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.ajog.2023.10.031_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/AOG.0000000000001902","article-title":"Consensus bundle on maternal mental health: perinatal depression and anxiety","volume":"129","author":"Kendig","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.reprotox.2018.08.018","article-title":"Ondansetron and teratogenicity in rats: evidence for a mechanism mediated via embryonic hERG blockade","volume":"81","author":"Danielsson","year":"2018","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2023.10.031_bib76","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring","volume":"320","author":"Huybrechts","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.10.031_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejogrb.2005.11.035","article-title":"Population-based case-control study of allergic rhinitis during pregnancy for birth outcomes","volume":"131","author":"Somosk\u00f6vi","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.10.031_bib78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bjh.16529","article-title":"A\u00a0novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies","volume":"190","author":"van Campen","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/pd.3864","article-title":"Non-invasive prenatal diagnosis of beta-thalassemia and sickle-cell disease using pyrophosphorolysis-activated polymerization and melting curve analysis","volume":"32","author":"Phylipsen","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2023.10.031_bib81","author":"Kroger"},{"key":"10.1016\/j.ajog.2023.10.031_bib82","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/s41467-022-30052-w","article-title":"Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy","volume":"13","author":"Prasad","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2023.10.031_bib83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10995-019-02844-y","article-title":"Influenza vaccine efficacy and effectiveness in pregnant women: systematic review and meta-analysis","volume":"24","author":"Quach","year":"2020","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajog.2023.10.031_bib84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajog.2023.10.031_bib85","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/16078454.2022.2085072","article-title":"COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis","volume":"27","author":"Friedman","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.ajog.2023.10.031_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib87","first-page":"816","article-title":"Use of 13-valent Pneumococcal Conjugate Vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib88","first-page":"CD011130","article-title":"Folate supplementation in people with sickle cell disease","volume":"2","author":"Dixit","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.10.031_bib89","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12884-020-03326-8","article-title":"Iron stores in pregnant women with sickle cell disease: a systematic review","volume":"20","author":"Aroke","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2023.10.031_bib90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.10.031_bib91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2016.19438","article-title":"Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.10.031_bib92","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.2016.19193","article-title":"Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Viswanathan","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.10.031_bib93","first-page":"803","article-title":"Genitourinary complications of sickle cell disease","volume":"166","author":"Bruno","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ajog.2023.10.031_bib94","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2023.10.031_bib95","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/1471-0528.16696","article-title":"Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort","volume":"128","author":"Lewis","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.10.031_bib96","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjh.15270","article-title":"Risk factors for vitamin D deficiency in sickle cell disease","volume":"181","author":"Han","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib97","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318227f06b","article-title":"ACOG Committee Opinion No. 495: vitamin D: screening and supplementation during pregnancy","volume":"118","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib98","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ajog.2023.10.031_bib99","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/jpm-2013-0275","article-title":"Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births","volume":"42","author":"Alayed","year":"2014","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib100","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/AOG.0000000000004251","article-title":"Fetal growth restriction","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib101","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012)","volume":"223","author":"Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib102","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/AOG.0000000000004407","article-title":"Indications for Outpatient Antenatal Fetal Surveillance: ACOG committee opinion, Number 828","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib103","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.AOG.0000285995.41769.83","article-title":"Perinatal and maternal outcomes in women with sickle or hemoglobin C trait","volume":"110","author":"Tita","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.05.002","article-title":"Pregnancy in sickle cell-haemoglobin C (SC) disease. A retrospective study of birth size and maternal weight gain","volume":"203","author":"Thame","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.10.031_bib105","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib106","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib107","author":"Friend"},{"key":"10.1016\/j.ajog.2023.10.031_bib108","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjh.13348","article-title":"Guideline on the management of acute chest syndrome in sickle cell disease","volume":"169","author":"Howard","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib109","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.suc.2007.12.005","article-title":"Physiologic changes in pregnancy","volume":"88","author":"Hill","year":"2008","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ajog.2023.10.031_bib110","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"ACOG Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/toxsci\/kfm084","article-title":"Ketamine-induced neuronal cell death in the perinatal rhesus monkey","volume":"98","author":"Slikker","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ajog.2023.10.031_bib112","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/ALN.0b013e318242b2cd","article-title":"Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain","volume":"116","author":"Brambrink","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajog.2023.10.031_bib113","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/AOG.0000000000005200","article-title":"Screening and diagnosis of mental health conditions during pregnancy and postpartum: ACOG Clinical Practice Guideline No. 4","volume":"141","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib114","first-page":"83","article-title":"Comparative teratogenicity of chlordiazepoxide, amitriptyline, and a combination of the two compounds in the fetal hamster","volume":"3","author":"Guram","year":"1982","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ajog.2023.10.031_bib115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/tera.1420300106","article-title":"Incidence and potentiation of external and internal fetal anomalies resulting from chlordiazepoxide and amitriptyline alone and in combination","volume":"30","author":"Beyer","year":"1984","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2023.10.031_bib117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-9343(94)90136-8","article-title":"Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes","volume":"96","author":"Hassell","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib118","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib122","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3949\/ccjm.83a.15172","article-title":"Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy","volume":"83","author":"Tobin","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib123","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.15537\/smj.2020.10.25386","article-title":"Outcomes of multidisciplinary team interventions in the management of sickle cell disease patients with opioid use disorders. A retrospective cohort study","volume":"41","author":"Al Zahrani","year":"2020","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ajog.2023.10.031_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0039-1700865","article-title":"Neonatal abstinence syndrome among infants born to mothers with sickle cell hemoglobinopathies","volume":"37","author":"Brown","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.10.031_bib126","first-page":"163","article-title":"Opioid utilization by pregnant women with sickle cell disease and the risk of neonatal abstinence syndrome","volume":"110","author":"Nnoli","year":"2018","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.ajog.2023.10.031_bib127","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ajh.24307","article-title":"Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease","volume":"91","author":"Shirel","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib128","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal Opioid Withdrawal Syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2023.10.031_bib129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/ANC.0000000000000581","article-title":"Eat, sleep, console approach: a family-centered model for the treatment of neonatal abstinence syndrome","volume":"19","author":"Grisham","year":"2019","journal-title":"Adv Neonatal Care"},{"key":"10.1016\/j.ajog.2023.10.031_bib130","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa2214470","article-title":"Eat, sleep, console approach or usual care for neonatal opioid withdrawal","volume":"388","author":"Young","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib131","first-page":"576","article-title":"Neonatal abstinence syndrome: prevention, recognition, treatment, and follow-up","volume":"74","author":"Schroeder","year":"2021","journal-title":"S\u00a0D Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib132","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pcl.2018.12.006","article-title":"Neonatal abstinence syndrome","volume":"66","author":"Jansson","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ajog.2023.10.031_bib133","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study","volume":"319","author":"Koshy","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib134","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2015-06-649319","article-title":"Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis","volume":"126","author":"Malinowski","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2023.10.031_bib135","first-page":"CD010378","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","volume":"2016","author":"Okusanya","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.10.031_bib136","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib137","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2023.10.031_bib138","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/asheducation-2013.1.447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"2013","author":"Porter","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ajog.2023.10.031_bib139","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/AOG.0000000000002528","article-title":"ACOG Practice Bulletin No. 192: management of alloimmunization during pregnancy","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia--diagnosis and management","volume":"212","author":"Mari","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib141","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/hematology.2021000308","article-title":"Management of hemolytic transfusion reactions","volume":"2021","author":"Hendrickson","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ajog.2023.10.031_bib142","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.hoc.2019.01.014","article-title":"Sickle cell disease: monitoring, current treatment, and therapeutics under development","volume":"33","author":"Hoppe","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ajog.2023.10.031_bib143","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdrb.20123","article-title":"NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea","volume":"80","author":"Liebelt","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2023.10.031_bib144","first-page":"1046","article-title":"Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia","volume":"101","author":"Ballas","year":"2009","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.ajog.2023.10.031_bib145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.11124\/JBISRIR-2017-003548","article-title":"Prevalence and incidence of congenital\u00a0anomalies amongst babies born to women with sickle cell disease\u00a0and exposed to hydroxyurea during pregnancy: a systematic review protocol","volume":"16","author":"Gwer","year":"2018","journal-title":"JBI Database Syst Rev Implement Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib146","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib147","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archinte.1981.00340070071015","article-title":"Arterial blood pressure in adults with sickle cell disease","volume":"141","author":"Johnson","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib148","first-page":"326","article-title":"Arterial blood pressure in adult Nigerians with sickle cell anemia","volume":"56","author":"Oguanobi","year":"2010","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.ajog.2023.10.031_bib149","first-page":"114","article-title":"Arterial blood pressure in adult Nigerian sickle cell anaemia patients","volume":"18","author":"Aderibigbe","year":"1999","journal-title":"West Afr J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib150","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00007611-200093060-00009","article-title":"Blood pressure in acute vaso-occlusive crises of sickle cell disease","volume":"93","author":"Ernst","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.ajog.2023.10.031_bib151","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000517703","article-title":"Sickle cell disease and the kidney: pathophysiology and novel biomarkers","volume":"199","author":"Lemes","year":"2021","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ajog.2023.10.031_bib152","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib153","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","article-title":"Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines","volume":"22","author":"Sinkey","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib154","first-page":"e1","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib155","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/AOG.0000000000004447","article-title":"Medically indicated late-preterm and early-term deliveries: ACOG committee opinion, Number 831","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib156","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1067\/mob.2001.107203","article-title":"Pregnancy after avascular necrosis of the femur complicating Gaucher\u2019s disease","volume":"184","author":"Cleary","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib157","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.10.031_bib158","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A\u00a0comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The preoperative transfusion in sickle cell disease study group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib159","first-page":"164","article-title":"Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell","volume":"28","author":"Al-Jaouni","year":"2006","journal-title":"anaemia"},{"key":"10.1016\/j.ajog.2023.10.031_bib160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/17474086.2019.1583554","article-title":"Overcoming challenges of venous thromboembolism in sickle cell disease treatment","volume":"12","author":"Ogunsile","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib161","first-page":"805","article-title":"Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism","volume":"31","author":"Porter","year":"2014","journal-title":"Am J Perinatol"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.10.031_bib162","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0049-3848(15)50442-8","article-title":"Sickle cell disease and venous thromboembolism in pregnancy and the puerperium","volume":"135","author":"Noubouossie","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2023.10.031_bib163","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199509143331104","article-title":"Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases","volume":"333","author":"Bellet","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib164","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MPH.0b013e31821ed4ce","article-title":"The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome","volume":"33","author":"Ahmad","year":"2011","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.ajog.2023.10.031_bib165","first-page":"131","volume":"17","author":"Chou","year":"2016","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.ajog.2023.10.031_bib167","doi-asserted-by":"crossref","first-page":"601.e9","DOI":"10.1016\/j.amjmed.2016.12.010","article-title":"Risk factors for 30-day readmission in adults with sickle cell disease","volume":"130","author":"Brodsky","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib168","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/pds.4860","article-title":"National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017","volume":"28","author":"Su","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2023.10.031_bib169","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ajh.26818","article-title":"Pregnancy outcomes in women with sickle cell disease in California","volume":"98","author":"Adesina","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib171","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.contraception.2011.10.008","article-title":"Contraception for individuals with sickle cell disease: a systematic review of the literature","volume":"85","author":"Haddad","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2023.10.031_bib172","first-page":"552","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception","volume":"113","author":"Pecker","year":"2021","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.ajog.2023.10.031_bib173","first-page":"1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib174","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.031_bib175","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2019.02.011","article-title":"Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: immediate postpartum long-acting reversible contraception for women at high risk for medical complications","volume":"220","author":"Vricella","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib176","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2021.09.005","article-title":"The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease","volume":"105","author":"Sinkey","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2023.10.031_bib177","first-page":"CD006261","article-title":"Steroid hormones for contraception in women with sickle cell disease","volume":"2","author":"Manchikanti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.10.031_bib178","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2023011008","article-title":"Contraception, pregnancy, and STI counseling and care among transitioning young adults with sickle cell disease","author":"Shankar","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpeds.2020.02.002","article-title":"Hydroxyurea exposure in lactation: a pharmacokinetics study (HELPS)","volume":"222","author":"Ware","year":"2020","journal-title":"J Pediatr."},{"key":"10.1016\/j.ajog.2023.10.031_bib182","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpeds.2020.02.002","article-title":"Hydroxyurea exposure in lactation: a pharmacokinetics study (HELPS)","volume":"222","author":"Ware","year":"2020","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2023.10.031_bib183","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.rpped.2014.11.006","article-title":"[Breastfeeding and the anthropometric profile of children with sickle cell anemia receiving follow-up in a newborn screening reference service]","volume":"33","author":"Nogueira","year":"2015","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.ajog.2023.10.031_bib184","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-med-120611-143127","article-title":"Sickle cell disease, vasculopathy, and therapeutics","volume":"64","author":"Kassim","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.wneu.2019.11.137","article-title":"Outcomes in patients with Moyamoya syndrome and sickle cell disease: a systematic review","volume":"135","author":"Newman","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ajog.2023.10.031_bib186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fneur.2019.00015","article-title":"Characteristics of Moyamoya syndrome in sickle-cell disease by magnetic resonance angiography: an adult-cohort study","volume":"10","author":"Kauv","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.ajog.2023.10.031_bib187","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2009.1.FOCUS08310","article-title":"Moyamoya disease: a summary","volume":"26","author":"Burke","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ajog.2023.10.031_bib188","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","article-title":"Management of stroke in infants and children: a scientific statement from a Special Writing Group\u00a0of\u00a0the American Heart Association Stroke Council and the Council\u00a0on Cardiovascular Disease in the Young","volume":"39","author":"Roach","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ajog.2023.10.031_bib189","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.wneu.2018.10.071","article-title":"Moyamoya disease in pregnancy: a 20-year single-center experience and literature review","volume":"122","author":"Inayama","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ajog.2023.10.031_bib190","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1055\/s-0039-1695743","article-title":"Adverse pregnancy outcomes in women with sickle cell trait","volume":"9","author":"Wellenstein","year":"2019","journal-title":"AJP Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064141","article-title":"Sickle cell trait: is there an increased\u00a0VTE risk in pregnancy and the postpartum?","volume":"8","author":"Pintova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.10.031_bib192","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.34274","article-title":"Evaluation of stillbirth among pregnant people with sickle cell trait","volume":"4","author":"Canel\u00f3n","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2023.10.031_bib193","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bjh.16518","article-title":"Pregnancy in sickle cell trait: what we do and don\u2019t know","volume":"190","author":"Wilson","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib194","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0020-7292(90)90649-6","article-title":"Sickle trait and its association with birthweight and urinary tract infections in pregnancy","volume":"33","author":"Baill","year":"1990","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2023.10.031_bib195","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ajog.2005.11.022","article-title":"Bacteriuria in pregnant women with sickle cell trait","volume":"194","author":"Thurman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib196","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0033354919881438","article-title":"Reducing health care disparities in sickle cell disease: a review","volume":"134","author":"Lee","year":"2019","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ajog.2023.10.031_bib197","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/ACM.0000000000004374","article-title":"Academic Medicine\u2019s journey toward racial equity must be grounded in history: recommendations for becoming an antiracist Academic Medical Center","volume":"96","author":"Wilkins","year":"2021","journal-title":"Acad Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib198","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.socscimed.2013.09.006","article-title":"Systemic racism and U.S. health care","volume":"103","author":"Feagin","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib199","doi-asserted-by":"crossref","first-page":"e4528","DOI":"10.1097\/MD.0000000000004528","article-title":"Quality of care in sickle cell disease: cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care","volume":"95","author":"Evensen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2023.10.031_bib200","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajog.2023.10.031_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265342","article-title":"Perspectives of individuals with sickle cell disease on barriers to care","volume":"17","author":"Phillips","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.10.031_bib202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/17474086.2016.1180242","article-title":"Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to\u00a0care, social issues, and adherence","volume":"9","author":"Adams-Graves","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib203","doi-asserted-by":"crossref","first-page":"531","DOI":"10.14423\/SMJ.0000000000000331","article-title":"Primary care providers\u2019 comfort levels in caring for patients with sickle cell disease","volume":"108","author":"Whiteman","year":"2015","journal-title":"South Med J"},{"key":"10.1016\/j.ajog.2023.10.031_bib204","first-page":"968","article-title":"Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network","volume":"100","author":"Lanzkron","year":"2008","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.ajog.2023.10.031_bib205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1553-2712.2007.tb01801.x","article-title":"Emergency department management of acute pain episodes in sickle cell disease","volume":"14","author":"Tanabe","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib206","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.2015.3075","article-title":"Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea","volume":"313","author":"Stettler","year":"2015","journal-title":"JAMA"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.10.031_bib207","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.amepre.2016.02.011","article-title":"Determining adherence to quality indicators in sickle cell anemia using multiple data sources","volume":"51","author":"Neunert","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib208","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1737","article-title":"Comparison of US federal and foundation funding of research for sickle cell disease and cystic fibrosis and factors associated with research productivity","volume":"3","author":"Farooq","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2023.10.031_bib209","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1073\/pnas.1516047113","article-title":"Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites","volume":"113","author":"Hoffman","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2023.10.031_bib210","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/AOG.0000000000003561","article-title":"Racial disparities in postpartum pain management","volume":"134","author":"Badreldin","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib211","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.amepre.2016.09.024","article-title":"Perceived discrimination and privilege in health care: the role of socioeconomic status and race","volume":"52","author":"Stepanikova","year":"2017","journal-title":"Am J Prev Med"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.10.031_bib212","article-title":"The strangest of all encounters: racial and ethnic discrimination in US health care","volume":"33","author":"James","year":"2017","journal-title":"Cad Sa\u00fade Publ"},{"key":"10.1016\/j.ajog.2023.10.031_bib213","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00007611-200093050-00007","article-title":"Physicians\u2019 attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative","volume":"93","author":"Weinstein","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.ajog.2023.10.031_bib214","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"FitzGerald","year":"2017","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.ajog.2023.10.031_bib215","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/j.pain.0000000000000536","article-title":"Health care providers\u2019 judgments in chronic pain: the influence of gender and trustworthiness","volume":"157","author":"Sch\u00e4fer","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.ajog.2023.10.031_bib216","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/a0035204","article-title":"Racial\/ethnic disparities in the assessment and treatment of pain: psychosocial perspectives","volume":"69","author":"Tait","year":"2014","journal-title":"Am Psychol"},{"key":"10.1016\/j.ajog.2023.10.031_bib217","first-page":"13","article-title":"The girl who cried pain: a bias against women in the treatment of pain","volume":"29","author":"Hoffmann","year":"2001","journal-title":"J\u00a0Law Med Ethics"},{"key":"10.1016\/j.ajog.2023.10.031_bib218","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2352-3026(20)30183-6","article-title":"Addressing bias towards patients with sickle cell disease","volume":"7","author":"DeLaune","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ajog.2023.10.031_bib219","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13557858.2011.552712","article-title":"Race and social attitudes about sickle cell disease","volume":"16","author":"Bediako","year":"2011","journal-title":"Ethn Health"},{"key":"10.1016\/j.ajog.2023.10.031_bib220","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jpainsymman.2014.02.002","article-title":"Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease","volume":"48","author":"Haywood","year":"2014","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.ajog.2023.10.031_bib221","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/AJP.0000000000000361","article-title":"Multiple levels of suffering: discrimination in health-care settings is associated with enhanced laboratory pain sensitivity in sickle cell disease","volume":"32","author":"Mathur","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ajog.2023.10.031_bib222","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.6016","article-title":"Perceptions of US adolescents and adults with sickle cell disease on their quality of care","volume":"3","author":"Kanter","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2023.10.031_bib223","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15265161.2013.767954","article-title":"Sickle cell disease and the \u201ddifficult patient\u201d conundrum","volume":"13","author":"Bergman","year":"2013","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.ajog.2023.10.031_bib224","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10865-005-9042-3","article-title":"Factors affecting hospital staff judgments about sickle cell disease pain","volume":"29","author":"Elander","year":"2006","journal-title":"J\u00a0Behav Med"},{"key":"10.1016\/j.ajog.2023.10.031_bib225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/ACO.0000000000001139","article-title":"Do racial and ethnic disparities lead to the undertreatment of pain? Are there solutions?","volume":"35","author":"Goree","year":"2022","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.ajog.2023.10.031_bib226","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/j.ajog.2020.12.1200","article-title":"Society for Maternal-Fetal Medicine Special Statement: grading of Recommendations Assessment, Development, and Evaluation (GRADE) update","volume":"224","author":"Norton","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.031_bib227","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clin Res Ed)"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:45:37Z","timestamp":1757591137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823007676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":217,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0002937823007676"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.10.031","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}